DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 5203--------------------------------------------------
       (Abst.) Transitioning from intravenous to subcutaneous
       ocrelizumab in a high-volume infusion center...
   DIR By: agate
       Date: June 10, 2026, 1:12 am
       ---------------------------------------------------------
       From PubMed (June 9, 2026)--"Transitioning from intravenous to
       subcutaneous ocrelizumab in a high-volume infusion center: A
       time-and-motion-informed capacity and service-flow analysis":
  HTML https://pubmed.ncbi.nlm.nih.gov/42259159/
       *****************************************************
       Page 1 of 1